1st Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVAVAX, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

LobbyistCovered position, as disclosed
SCOTT DOUGLAS —
JAMES GERARD FLOOD —
STEPHEN HOLLAND —
TIM SHADYAC —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4121 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.